产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# BF0300, RRID:AB_2833498.
展开/折叠
BAT26; COCA 1; COCA1; DNA mismatch repair protein Msh2; FCC 1; FCC1; hMSH2; HNPCC 1; HNPCC; HNPCC1; LCFS2; MSH 2; Msh2; MSH2_HUMAN; MutS homolog 2; MutS homolog 2 colon cancer nonpolyposis type 1; MutS protein homolog 2;
抗原和靶标
Purified recombinant fragment of human MSH2 expressed in E. Coli.
- P43246 MSH2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAVQPKETLQLESAAEVGFVRFFQGMPEKPTTTVRLFDRGDFYTAHGEDALLAAREVFKTQGVIKYMGPAGAKNLQSVVLSKMNFESFVKDLLLVRQYRVEVYKNRAGNKASKENDWYLAYKASPGNLSQFEDILFGNNDMSASIGVVGVKMSAVDGQRQVGVGYVDSIQRKLGLCEFPDNDQFSNLEALLIQIGPKECVLPGGETAGDMGKLRQIIQRGGILITERKKADFSTKDIYQDLNRLLKGKKGEQMNSAVLPEMENQVAVSSLSAVIKFLELLSDDSNFGQFELTTFDFSQYMKLDIAAVRALNLFQGSVEDTTGSQSLAALLNKCKTPQGQRLVNQWIKQPLMDKNRIEERLNLVEAFVEDAELRQTLQEDLLRRFPDLNRLAKKFQRQAANLQDCYRLYQGINQLPNVIQALEKHEGKHQKLLLAVFVTPLTDLRSDFSKFQEMIETTLDMDQVENHEFLVKPSFDPNLSELREIMNDLEKKMQSTLISAARDLGLDPGKQIKLDSSAQFGYYFRVTCKEEKVLRNNKNFSTVDIQKNGVKFTNSKLTSLNEEYTKNKTEYEEAQDAIVKEIVNISSGYVEPMQTLNDVLAQLDAVVSFAHVSNGAPVPYVRPAILEKGQGRIILKASRHACVEVQDEIAFIPNDVYFEKDKQMFHIITGPNMGGKSTYIRQTGVIVLMAQIGCFVPCESAEVSIVDCILARVGAGDSQLKGVSTFMAEMLETASILRSATKDSLIIIDELGRGTSTYDGFGLAWAISEYIATKIGAFCMFATHFHELTALANQIPTVNNLHVTALTTEETLTMLYQVKKGVCDQSFGIHVAELANFPKHVIECAKQKALELEEFQYIGESQGYDIMEPAAKKCYLEREQGEKIIQEFLSKVKQMPFTEMSEENITIKLKQLKAEVIAKNNSFVNEIISRIKVTT
翻译修饰 - P43246 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
K65 | Ubiquitination | Uniprot | |
Y66 | Phosphorylation | Uniprot | |
K73 | Acetylation | Uniprot | |
K73 | Ubiquitination | Uniprot | |
S77 | Phosphorylation | Uniprot | |
K104 | Acetylation | Uniprot | |
K104 | Methylation | Uniprot | |
K113 | Acetylation | Uniprot | |
K172 | Ubiquitination | Uniprot | |
T206 | Phosphorylation | Uniprot | |
K212 | Ubiquitination | Uniprot | |
R219 | Methylation | Uniprot | |
K235 | Ubiquitination | Uniprot | |
Y238 | Phosphorylation | Uniprot | |
K249 | Ubiquitination | Uniprot | |
K332 | Ubiquitination | Uniprot | |
K347 | Ubiquitination | Uniprot | |
K430 | Sumoylation | Uniprot | |
S479 | Phosphorylation | Uniprot | |
K491 | Ubiquitination | Uniprot | |
K509 | Ubiquitination | Uniprot | |
K531 | Ubiquitination | Uniprot | |
K537 | Ubiquitination | Uniprot | |
K550 | Acetylation | Uniprot | |
K555 | Acetylation | Uniprot | |
K555 | Ubiquitination | Uniprot | |
S558 | Phosphorylation | Uniprot | |
Y563 | Phosphorylation | Uniprot | |
K565 | Ubiquitination | Uniprot | |
K567 | Ubiquitination | Uniprot | |
Y570 | Phosphorylation | Uniprot | |
K635 | Acetylation | Uniprot | |
K635 | Ubiquitination | Uniprot | |
S717 | Phosphorylation | Uniprot | |
K720 | Ubiquitination | Uniprot | |
S738 | Phosphorylation | Uniprot | |
T740 | Phosphorylation | Uniprot | |
K741 | Ubiquitination | Uniprot | |
S743 | Phosphorylation | Uniprot | |
K845 | Ubiquitination | Uniprot | |
S860 | Phosphorylation | Uniprot | |
Y863 | Phosphorylation | Uniprot | |
K871 | Ubiquitination | Uniprot | |
K872 | Ubiquitination | Uniprot | |
K882 | Ubiquitination | Uniprot | |
K892 | Ubiquitination | Uniprot | |
T897 | Phosphorylation | Uniprot | |
S900 | Phosphorylation | Uniprot | |
K912 | Ubiquitination | Uniprot | |
K918 | Ubiquitination | Uniprot | |
S921 | Phosphorylation | Uniprot |
研究背景
Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis.
Phosphorylated by PRKCZ, which may prevent MutS alpha degradation by the ubiquitin-proteasome pathway.
Nucleus. Chromosome.
Ubiquitously expressed.
Component of the DNA mismatch repair (MMR) complex composed at least of MSH2, MSH3, MSH6, PMS1 and MLH1. Heterodimer consisting of MSH2-MSH6 (MutS alpha) or MSH2-MSH3 (MutS beta). Both heterodimers form a ternary complex with MutL alpha (MLH1-PMS1). Interacts with MCM9; the interaction recruits MCM9 to chromatin. Interacts with MCM8. Interacts with EXO1. Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ATR. Interacts with SLX4/BTBD12; this interaction is direct and links MutS beta to SLX4, a subunit of different structure-specific endonucleases. Interacts with SMARCAD1.
Belongs to the DNA mismatch repair MutS family.
研究领域
· Genetic Information Processing > Replication and repair > Mismatch repair.
· Human Diseases > Drug resistance: Antineoplastic > Platinum drug resistance.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Colorectal cancer. (View pathway)
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.